Markets face 'normalization on steroids' in 2025, says BMO's Brian Belski
Brian Belski, chief investment strategist at BMO Capital Markets , talks with Financial Post’s Larysa Harapyn about how this ...
U.S. manufacturers show signs of recovery from 2-year slump. But they still face headwinds.
Durable-goods orders could get a lift from business-friendly Trump White House Sales of big-ticket manufactured goods and overall U.S. business investment showed signs of revival toward the end of ...